VENMAX
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Venmax Drugs To Consider Merger With Hatri Pharma
Aug 25 (Reuters) - Venmax Drugs and Pharmaceuticals Ltd VENM.BO:
VENMAX DRUGS AND PHARMACEUTICALS LTD - VENMAX TO CONSIDER MERGER WITH HATRI PHARMA
Source text: ID:nBSE6b1m09
Further company coverage: VENM.BO
Aug 25 (Reuters) - Venmax Drugs and Pharmaceuticals Ltd VENM.BO:
VENMAX DRUGS AND PHARMACEUTICALS LTD - VENMAX TO CONSIDER MERGER WITH HATRI PHARMA
Source text: ID:nBSE6b1m09
Further company coverage: VENM.BO
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Venmax Drugs&Pharma do?
Venmax Drugs and Pharmaceuticals is engaged in the business of pharmaceutical products, drug intermediates, and active pharmaceutical ingredients. The company’s registered office is located in Hyderabad, Telangana.
Who are the competitors of Venmax Drugs&Pharma?
Venmax Drugs&Pharma major competitors are Omkar Pharmachem, Medistep Healthcare, Guj. Terce Lab, Medicamen Organics, Unick Fix-A-Form, Chandra Bhagat Pharm, Ishita Drugs & Inds.. Market Cap of Venmax Drugs&Pharma is ₹27 Crs. While the median market cap of its peers are ₹26 Crs.
Is Venmax Drugs&Pharma financially stable compared to its competitors?
Venmax Drugs&Pharma seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Venmax Drugs&Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Venmax Drugs&Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Venmax Drugs&Pharma allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances
How strong is Venmax Drugs&Pharma balance sheet?
Balance sheet of Venmax Drugs&Pharma is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Venmax Drugs&Pharma improving?
No, profit is decreasing. The profit of Venmax Drugs&Pharma is -₹0.01 Crs for Mar 2025, ₹0.06 Crs for Mar 2024 and ₹0.23 Crs for Mar 2023
Is the debt of Venmax Drugs&Pharma increasing or decreasing?
Yes, The net debt of Venmax Drugs&Pharma is increasing. Latest net debt of Venmax Drugs&Pharma is -₹0.89 Crs as of Mar-26. This is greater than Mar-25 when it was -₹4.92 Crs.
Is Venmax Drugs&Pharma stock expensive?
Yes, Venmax Drugs&Pharma is expensive. Latest PE of Venmax Drugs&Pharma is 112, while 3 year average PE is 15.87. Also latest EV/EBITDA of Venmax Drugs&Pharma is 371 while 3yr average is 5.38.
Has the share price of Venmax Drugs&Pharma grown faster than its competition?
Venmax Drugs&Pharma has given better returns compared to its competitors. Venmax Drugs&Pharma has grown at ~-13.35% over the last 1yrs while peers have grown at a median rate of -22.0%
Is the promoter bullish about Venmax Drugs&Pharma?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Venmax Drugs&Pharma is 13.8% and last quarter promoter holding is 15.14%
Are mutual funds buying/selling Venmax Drugs&Pharma?
There is Insufficient data to gauge this.